首页> 外文期刊>Journal of microbiology and biotechnology >The orientation-dependent expression of angiostatin-endostatin hybrid proteins and their characterization for the synergistic effects of antiangiogenesis
【24h】

The orientation-dependent expression of angiostatin-endostatin hybrid proteins and their characterization for the synergistic effects of antiangiogenesis

机译:血管抑素-内皮抑素杂合蛋白的方向依赖性表达及其抗血管生成协同作用的表征

获取原文
获取原文并翻译 | 示例
           

摘要

Two angiostatic fusion proteins (hAE and hEA), differing in tandem connection manners, were constructed from human angiostatin (hAS) and endostatin (hES) proteins. These fusion proteins were then evaluated for synergistic antiangiogenic properties. The 65 kDa secreted fusion proteins, expressed in Pichia pastoris, were verified by both mass analysis and Western blotting assay. Luciferase reporter gene assay, using a VEGF promoter, revealed that the angiostatin-endostatin fusion protein (hAE), and its corresponding fusion gene delivery on human microvascular endothelial cells (HMEC-1), resulted in a more potent synergistic antiangiogenic effect than the endostatin-angiostatin fusion protein (hEA). These results suggest that the orientation of the fusion genes in hAS and hES might be an important factor in the development of therapeutic proteins.
机译:从人血管抑素(hAS)和内皮抑素(hES)蛋白构建了两种串联连接方式不同的血管抑制融合蛋白(hAE和hEA)。然后评估这些融合蛋白的协同抗血管生成特性。巴斯德毕赤酵母中表达的65 kDa分泌的融合蛋白通过质量分析和Western印迹法验证。使用VEGF启动子的萤光素酶报告基因检测表明,血管抑素-内皮抑素融合蛋白(hAE)及其相应的融合基因在人微血管内皮细胞(HMEC-1)上的递送比内皮抑素产生更强的协同抗血管生成作用-血管抑制素融合蛋白(hEA)。这些结果表明,hAS和hES中融合基因的方向可能是治疗性蛋白质开发中的重要因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号